Tredje AP fonden grew its stake in Waters Corporation (NYSE:WAT) by 247.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,430 shares of the medical instruments supplier’s stock after buying an additional 8,850 shares during the period. Tredje AP fonden’s holdings in Waters Corporation were worth $2,285,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Waters Corporation by 3.0% in the first quarter. Vanguard Group Inc. now owns 7,497,760 shares of the medical instruments supplier’s stock worth $1,171,975,000 after buying an additional 216,162 shares during the last quarter. BlackRock Inc. increased its stake in shares of Waters Corporation by 2,810.7% in the first quarter. BlackRock Inc. now owns 5,349,711 shares of the medical instruments supplier’s stock worth $836,212,000 after purchasing an additional 5,165,917 shares during the period. State Street Corp increased its stake in shares of Waters Corporation by 1.7% in the first quarter. State Street Corp now owns 3,446,000 shares of the medical instruments supplier’s stock worth $538,641,000 after purchasing an additional 58,746 shares during the period. Fundsmith LLP increased its stake in shares of Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock worth $536,540,000 after purchasing an additional 349,178 shares during the period. Finally, Janus Capital Management LLC increased its stake in shares of Waters Corporation by 18.2% in the first quarter. Janus Capital Management LLC now owns 2,309,646 shares of the medical instruments supplier’s stock worth $361,021,000 after purchasing an additional 356,395 shares during the period. 91.00% of the stock is owned by institutional investors.
Shares of Waters Corporation (NYSE:WAT) opened at 187.73 on Monday. The company has a market cap of $14.99 billion, a PE ratio of 28.29 and a beta of 0.83. The company has a 50 day moving average of $181.05 and a 200-day moving average of $173.48. Waters Corporation has a 52-week low of $133.35 and a 52-week high of $190.39.
Waters Corporation (NYSE:WAT) last issued its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.05. Waters Corporation had a net margin of 24.26% and a return on equity of 23.91%. The company had revenue of $558.30 million during the quarter, compared to analysts’ expectations of $553.22 million. During the same period last year, the company posted $1.58 EPS. Waters Corporation’s revenue was up 4.0% on a year-over-year basis. Analysts forecast that Waters Corporation will post $7.38 EPS for the current fiscal year.
In other Waters Corporation news, SVP Rohit Khanna sold 18,400 shares of the firm’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $185.78, for a total transaction of $3,418,352.00. Following the completion of the sale, the senior vice president now directly owns 22,477 shares in the company, valued at approximately $4,175,777.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Christopher A. Kuebler sold 3,500 shares of Waters Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total transaction of $628,845.00. Following the completion of the sale, the director now owns 17,849 shares of the company’s stock, valued at $3,206,929.83. The disclosure for this sale can be found here. Company insiders own 5.07% of the company’s stock.
Several brokerages recently issued reports on WAT. Zacks Investment Research upgraded Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target on the stock in a research note on Thursday, July 13th. BidaskClub upgraded Waters Corporation from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 16th. Jefferies Group LLC reissued a “hold” rating and issued a $175.00 target price on shares of Waters Corporation in a report on Thursday, July 27th. Morgan Stanley reissued an “underweight” rating and issued a $183.00 target price (up from $174.00) on shares of Waters Corporation in a report on Wednesday, July 26th. Finally, Deutsche Bank AG downgraded Waters Corporation from a “buy” rating to a “hold” rating and boosted their target price for the stock from $183.00 to $194.00 in a report on Monday, July 10th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $186.00.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.